Related Experiment Video
Updated: Jul 15, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
Impact of the passive immunization campaign with nirsevimab in 2023-24 in Castellón. Final results
Eulalia Gregori-García1, Juan Carlos Gascó-Laborda2, Lledó Lluch-Bacas2
1Servicio de Medicina Preventiva, Hospital General Universitario de Castellón, Castellón, Spain; Sección de Epidemiología, Centro de Salud Pública de Castellón, Generalitat Valenciana, Castellón, Spain.
Introduction:
In the 2023-2024 season, systematic immunization with the monoclonal antibody nirsevimab was recommended in Spain. The impact that this immunization program had on the target population of the program is analyzed.
Methods:
Pre-post ecological study comparing 2023-24 vs 2022-23 season. The variation in incidence is described by age groups (0-5, 6-11 and 12-59 months) and hospitalization. Incidence rates were calculated and relative risks (RR) were estimated for each group.
Results:
The results were very heterogeneous depending on the age group. In children 0-5 months old the RR was 0.16 (0.10-0.25); in those aged 6-11 months, RR of 0.90 (0.56-1.42); and in those aged 12-59 months, RR 1.36 (1.06-1.74). The greatest decrease in risk was in hospitalized children under 6 months, RR 0.13 (0.07-0.22).
Conclusion:
The results support the positive impact that this campaign had, especially on hospitalizations.
More Related Videos
Related Concept Videos
Vaccinations
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines
Respiratory Syncytial Virus Disease

